http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0678027-B1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a717ea5b2ac78ac329ab3a9659d834d2 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 |
filingDate | 1993-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2001-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a19b410d498d4b27deb500499d9a9727 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2047095fc0a34dccf9e6e7d5af2b6338 |
publicationDate | 2001-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-0678027-B1 |
titleOfInvention | Anti-atherosclerotic agents |
abstract | A method for the treatment of atherosclerosis by administering to a patient in need of anti-atherosclerotic treatment, an effective amount of 17 alpha-dihydroequilin, a C2-C6 alkanoyloxy ester thereof or a pharmaceutically acceptable salt of its sulfate or phosphate ester, in the absence of naturally occurring estrogenic steroids. A pharmaceutical composition containing 17 alpha-dihydroequilin, a C2-C6 alkanoyloxy ester thereof or a pharmaceutically acceptable salt of its sulfate or phosphate ester, in the absence of naturally occurring estrogenic steroids, and a pharmaceuticallly acceptable carrier therefor. |
priorityDate | 1993-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 60.